Compare plans tailored to your home & budget. If you live in an area with cold winters, you know that forgetting to turn off your water and drain your pipes can have serious consequences. Frozen pipes ...

Authorities from Washington, D.C.‘s Water and Sewer Authority expect the full repair of the sewage pipe that ruptured near Cabin John, Maryland, to take over nine months. DC Water officials held a ...

A pipe coupling failure has caused about 70,000 gallons of water to drench the Rice Street Jail. The flooding started shortly after 5 a.m., the Fulton County Sheriff's Office said. No inmate housing ...

CAMBRIDGE, Mass. & MONTREAL — Repare Therapeutics Inc. (“Repare” or the “Company”) announced today the completion of the previously announced acquisition of all of the issued and outstanding common ...

Repare Therapeutics (RPTX) added ~20% in the premarket on Wednesday after the company announced an asset purchase agreement to sell its experimental cancer therapy RP-3467 to Gilead (GILD) in a deal ...

Climatetech startup TRST01 launched an AI-enabled, blockchain-verified Paris Agreement Integrated Platform (PAIP) at COP30, being held in Brazil. An AI-enabled, blockchain-verified climate governance ...

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that it has entered into a definitive arrangement agreement (the ...

From molten copper to finished fittings, the Virginia facility shows how a century-old manufacturer blends tradition with world-class automation. NIBCO purchased the Stuarts Draft facility in 1969.

Repare Therapeutics is a biotechnology company specializing in precision oncology. Its core strategy revolves around synthetic lethality, developing drugs that target cancer cells based on their ...

GAAP EPS loss significantly narrowed to $(0.39) for Q2 2025, GAAP EPS was $0.39, exceeding estimates by $0.95, mainly due to a one-time $5.7 million gain from a technology out-licensing deal.

Repare Therapeutics Inc, a clinical-stage precision oncology company, announced it has entered into an exclusive worldwide licensing agreement with Debiopharm International SA, a privately-owned, ...